Clamoxyl is a broad spectrum semi-synthetic penicillin which is bactericidal in vitro, against a wide range of Gram-positive and Gram-negative bacteria, including the following:
Gram-Negative | Gram-Positive |
Actinobacillus lignieresi | Bacillus anthracis |
Bordetella bronchiseptica | Clostridium spp. |
Escherichia coli | Corynebacterium spp. |
Fusobacterium spp. | Erysipelothrix rhusiopathiae |
Haemophilus spp. | streptococci and staphylococci (penicillin sensitive strains) |
Moraxella spp. | |
Pasteurella spp. | |
Proteus mirabilis | |
Salmonella spp. | |
Clamoxyl Long Acting Suspension for Injection is suitable for the control of infections caused by susceptible organisms in sheep, dogs and cats where prolonged activity from a single injection is required. It may also be used to control secondary bacterial invasion in conditions where bacteria are not a primary cause of disease.
Particular indications for Clamoxyl L.A. Injection are:
1Alimentary tract infections, including enteritis.
2Respiratory tract infections.
3Urogenital tract infections, including cystitis and metritis.
4Skin and soft tissue infections, including wounds, abscesses, foot infections, joint and navel ill.
5Prevention of post-operative infections by injection prior to surgery.